09 Jan 2019

ENDOLOGIX RECALLS NELLIX SYSTEM FOR PATIENT SAFETY

Endologix Inc., a developer and marketer of treatments for aortic disorders, has stopped unrestricted sales and use of the Nellix System in order to ensure optimal outcomes for patients. The existing inventory will be voluntarily recalled as described in a Field Safety Notification (FSN) issued in January. The Nellix System

0